Efficacy and safety of omalizumab in patients with chronic idiopathic urticaria who remain symptomatic despite concomitant H1 antihistamine therapy: results of a phase 2 trial

被引：0
|
作者：
Saini, S.
Rosen, K. [1 ]
Hsieh, H. [1 ]
Wong, D. [1 ]
Conner, E.
Doyle, R. [1 ]
Kaplan, A. [2 ]
Spector, S. [3 ]
Maurer, M. [4 ]
机构：
[1] Genentech Inc, San Francisco, CA USA
[2] Med Univ S Carolina, Charleston, SC USA
[3] Univ Calif Los Angeles, Los Angeles, CA 90024 USA
[4] Charite Univ Med Berlin, Berlin, Germany
来源：
ALLERGY | 2011年 / 66卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
67
引用
收藏
页码：33 / 33
页数：1
相关论文
共 50 条
  • [21] A randomized, placebo-controlled, dose-ranging study of single-dose omalizumab in patients with H1-antihistamine-refractory chronic idiopathic urticaria
    Saini, Sarbjit
    Rosen, Karin E.
    Hsieh, Hsin-Ju
    Wong, Dennis A.
    Conner, Edward
    Kaplan, Allen
    Spector, Sheldon
    Maurer, Marcus
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2011, 128 (03) : 567 - U195
  • [22] Dupilumab significantly reduces itch and hives in patients with chronic spontaneous urticaria (CSU) who remain symptomatic despite use of standard-of-care antihistamines: Results from a phase 3 trial (LIBERTY-CSU CUPID study A)
    Maurer, Marcus
    Casale, Thomas B.
    Saini, Sarbjit S.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 87 (03) : AB46 - AB46
  • [23] ANGIOEDEMA RESULTS FROM GLACIAL: A PHASE III, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE SAFETYAND EFFICACY OF OMALIZUMAB IN PATIENTS WITH CHRONIC IDIOPATHIC/SPONTANEOUS URTICARIA (CIU/CSU) RECEIVING CONCOMITANT H1 ANTI-HISTAMINES, H2 ANTIHISTAMINES, AND/OR LEUKOTRIENE RECEPTOR ANTAGONIST (LTRA) TREATMENT
    Zazzali, J.
    Raimundo, K.
    Ashby, M.
    Rosen, K.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2013, 111 (05) : A121 - A121
  • [24] Association of concomitant H1 antihistamine and immune checkpoint inhibitor therapy on survival outcome and safety in patients with advanced primary lung cancer: a cohort study
    Zhang, Wei-Hong
    Li, Bing-Xue
    Ma, Chen-Xi
    Wang, Jian
    Yang, Fan
    Xiong, Yan-Juan
    Li, Shu-Zhan
    Zhang, Jia-Li
    Du, Wei-Jiao
    Hui, Zhen-Zhen
    Shen, Meng
    Zhou, Li
    Li, Run-Mei
    Tian, Xiao
    Han, Ying
    Ren, Bao-Zhu
    Ichiki, Yoshinobu
    Lee, Sang Chul
    Zhang, Xin-Wei
    Cao, Shui
    Ren, Xiu-Bao
    Liu, Liang
    TRANSLATIONAL LUNG CANCER RESEARCH, 2024, 13 (10) : 2787 - 2801
  • [25] Effect of omalizumab on angioedema in H1-antihistamine-resistant chronic spontaneous urticaria patients: results from X-ACT, a randomized controlled trial (vol 71, pg 1135, 2016)
    Staubach, P.
    Metz, M.
    Chapman-Rothe, N.
    Sieder, C.
    Brautigam, M.
    Canvin, J.
    Maurer, M.
    ALLERGY, 2017, 72 (09) : 1430 - 1430
  • [26] Efficacy and Safety of Linaclotide in Chronic Idiopathic Constipation Patients With Abdominal Bloating: Phase 3b Trial Results
    Lacy, Brian E.
    Lembo, Anthony
    Schey, Ron
    Lavins, Bernard J.
    Eng, Paul F.
    Fox, Susan M.
    Jia, Xinwei D.
    Hao, Xinming
    Currie, Mark G.
    Kurtz, Caroline B.
    Johnston, Jeffrey
    Shiff, Steven J.
    GASTROENTEROLOGY, 2014, 146 (05) : S353 - S353
  • [27] Impact of concomitant H1 antihistamine administered during initiation of immune checkpoint inhibitor therapy on survival outcome and safety in patients with advanced primary lung cancer
    Zhang, Weihong
    Li, Bingxue
    Liu, Liang
    Ren, Xiubao
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [28] Efficacy of switching to bilastine, a histamine H1 receptor antagonist, in patients with chronic spontaneous urticaria (H1-SWITCH): study protocol for a randomized controlled trial
    Atsushi Fukunaga
    Yoshiko Oda
    Ken Washio
    Takashi Omori
    Yasumasa Kakei
    Michihiro Hide
    Chikako Nishigori
    Trials, 21
  • [29] Efficacy of switching to bilastine, a histamine H1 receptor antagonist, in patients with chronic spontaneous urticaria (H1-SWITCH): study protocol for a randomized controlled trial
    Fukunaga, Atsushi
    Oda, Yoshiko
    Washio, Ken
    Omori, Takashi
    Kakei, Yasumasa
    Hide, Michihiro
    Nishigori, Chikako
    TRIALS, 2020, 21 (01)
  • [30] A randomized open labeled trial to compare the efficacy of antihistamine dosing-up and add-on treatment with H2-receptor antagonist in patients with chronic urticaria
    Ye, Y.
    Choi, J.
    Kim, M.
    Shin, Y.
    Park, H.
    ALLERGY, 2020, 75 : 85 - 86
12345